Polyclonal anti-tumor necrosis factor-α Fab used as an ancillary treatment for severe malaria

American Journal of Tropical Medicine and Hygiene

Volumn 61, Issue 1, 1999, Pages 26-33

  Looareesuwan, S ^a   Sjostrom, L ^b   Krudsood, S ^a   Wilairatana, P ^a   Porter, R S ^b   Hills, F ^b   Warrell, D A ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; CELL ADHESION MOLECULE; CYTOKINE; CYTOTAB; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; IMMUNOGLOBULIN F(AB) FRAGMENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MEFLOQUINE; POLYCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; FEVER; GASTROINTESTINAL TOXICITY; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MALARIA FALCIPARUM; MALE; MUSCLE WEAKNESS; ORAL DRUG ADMINISTRATION; RIGOR;

EID: 0032789494     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.61.26     Document Type: Article

References (22)

1. Ketrangsee S, 1992. Status report of malaria in Thailand. Southeast Asian J Trop Med Public Health 23 (suppl 4): 67-68.
2. Warrell DA, Looareesuwan S, Warrell MJ, Kasemsarn P, Intaraprasert R, Bunnag D, Harinasuta T, 1982. Dexamethasone proves deleterious in cerebral malaria. N Engl J Med 306: 313-319.
3. Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassali P, Hommel M, Lambert PH, 1989. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 320: 1586-1591.
4. Kwiatkowski D, Hill AVS, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM, 1990. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336: 1201-1204.
5. McGuire W, Hill AVA, Allsopp CEM, Greenwood BM, Kwiatkowski D, 1994. Variation in the TNFα promoter region associated with susceptibility to cerebral malaria. Nature 371: 508-511.
6. Kwiatkowski D, Molyneux ME, Stephens S, Curtis N, Klein N, Pointaire P, Smit M, Allan R, Brewster DR, Grau GE, Greenwood BM, 1993. Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med 86: 91-98.
7. Hensbroek MB, Palmer A, Onyiorah E, Schneider G, Jaffar S, Dolan G, Memming H, Frenkel J, Enwere G, Bennett S, Kwiatkowski D, Greenwood B, 1996. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis 174: 1091-1097.
8. Fekade D, Knox K, Hussein K, Melka A, Lalloo DG, Coxon R, Warrell DA, 1996. Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor-α. N Engl J Med 335: 311-315.
9. World Health Organization, 1990. Severe and complicated malaria. Trans R Soc Trop Med Hyg 84 (suppl 2): 1-65.
10. Gibaldi M, Perrier D, 1982. Pharmacokinetics. New York, Marcel Dekker.
11. Coxon RE, Fekade D, Knox K, Hussein K, Melka A, Daniel A, Griffin GG, Warrell DA, 1997. The effect of antibody against TNFα on cytokine response in Jarisch-Herxheimer reaction of louse-borne relapsing fever. Q J Med 90: 213-221.
12. Hien TT, Day N, Phu NH, Mai NTH, Chau TTH, Sinh DX, Chuong LV, Vinh H, Waller D, Peto TEA, White NJ, 1996. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 335: 76-83.
13. Kremsner PG, Winkler S, Brandets C, Wildling E, Jenne L, Graninger W, Prada J, Bienzle U, Juillard P, Grau GE, 1995. Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production. Am J Trop Med Hyg 53: 532-538.
14. Hensbroek MB, Onyiorah E, Jaffar S, Schneider G, Palmer A, Frenkel J, Enwere G, Forck S, Nusmeijer A, Bennett S, Greenwood B, Kwiatkowski D, 1996. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 335: 69-75.
15. Brewer TG, Peggins JO, Grate SJ, Petra JM, Levine BS, Weina PJ, Swearengen J, Heiffer MH, Schuster BG, 1994. Neurotoxicity in animals due to arteether and artemether. Trans R Soc Trop Med Hyg 88 (suppl1): 33-36.
16. Looareesuwan S, Viravan C, Vanijanonta S, Wilairatana P, Charoenlarp P, Canfield C, Kyle DE, 1993. Treatment of acute uncomplicated falciparum malaria with a short course of artesunate followed by mefloquine. Southeast Asian J Trop Med Public Health 24: 230-234.
17. Eling WMC, Kremsner PG, 1994. Cytokines in malaria, pathology and protection. Biotherapy 7: 211-221.
18. Cubas ABC, Gentilini M, Monjour L, 1994. Cytokines and T-cell response in malaria. Biomed Pharmacother 48: 27-33.
19. Pongponratn E, Riganti M, Punpoowong B, Aikawa M, 1991. Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study. Am J Trop Med Hyg 44: 168-175.
20. Wenisch C, Vanijanonta S, Looareesuwan S, Graninger W, Pilcher R, Wernsdorfer W, 1994. Soluble intercellular adhesion molecule-1 (ICAM-1), endothelial leukocyte adhesion molecule-1 (ELAM-1), and tumor necrosis factor receptor (55 kDa TNF-R) in patients with acute Plasmodium falciparum malaria. Clin Immunol Immunopathol 71: 344-348.
21. Urtizberea M, Sabouraud A, Lachaise M, Chappey O, Cosson V, Baud FJ, Scherrmann JM, 1991. Pharmacokinetics of total and free digoxin and Fab fragments in 5 intoxicated patients after administration of specific anti-digoxin Fab fragments. Arch Toxicol 8: 132-135.
22. Schauman W, Kaufmann B, Neubert P, Smolarz A, 1986. Kinetics of the Fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication. Eur J Clin Pharmacol 30: 527-533.